OA02.03 Amivantamab Plus Lazertinib vs Osimertinib in First-line EGFR-mutant Advanced NSCLC: Longer Follow-up of the MARIPOSA Study
S. Gadgeel(Detroit R&D (United States)), B.C. Cho(Yonsei University), S. Lu(Shanghai Chest Hospital), E. Felip(Universitat Autònoma de Barcelona), Hidetoshi Hayashi(Kindai University), A.I. Spira(Virginia Cancer Specialists), B. Besse(Université Paris-Saclay), Michael Thomas(Heidelberg University), Scott Owen, Yoon Jun Kim(New Generation University College), S.-H. Lee(Samsung Medical Center), Josiane Mourão Dias(Hospital de Câncer de Barretos), Y.-G. Lee(Kangbuk Samsung Hospital), Yong Zhao(Henan Cancer Hospital), Yun Fang(Sir Run Run Shaw Hospital), N. Girard(Université de Versailles Saint-Quentin-en-Yvelines), Zhen Liu(Beijing Chest Hospital), Ping Sun(Yuhuangding Hospital), Sabrina Oliveira(Liga Contra el Cancer), Hong Shen(Second Affiliated Hospital of Zhejiang University), L. Paz-Ares(Hospital Universitario 12 De Octubre), Shingo Matsumoto(National Cancer Center Hospital East), Haruo Tanaka(Niigata Cancer Center Hospital), A.R. Ahmad, Т. Андабеков(Saint Petersburg State Pediatric Medical University), P. Sunpaweravong(Prince of Songkla University), Özgür Özyılkan(Başkent University), J.C.-H. Yang(National Taiwan University), Maya Gottfried(Meir Medical Center), Olga Susana Suárez Hernández(Integral Consulting (United States)), M. Kimmich(Robert Bosch Hospital), D. Cortinovis(University of Milano-Bicocca), D.L. Kaen(Hospital General de La Rioja), Lizbett Vanessa Garcia Montes(MSD (Mexico)), Sanjay Popat(Royal Marsden NHS Foundation Trust), Tom Newsom‐Davis(Chelsea and Westminster Hospital), Juanjuan Xie(Janssen (United States)), Tao Sun(Janssen (United States)), E. Fennema(Janssen (Belgium)), Mahesh Daksh(Janssen (United States)), Marguerite Ennis(Springhouse), Seema Sethi(Springhouse), Joshua Bauml(Springhouse), Dinh Chuong Nguyen(City Of Hope National Medical Center)
Cited by 9Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis